Sign In
Buy OPGN
$24.75
+0 (+0%)
At Close: Jun 02, 2026
OpGen's (OPGN) CEO Oliver Schacht on Q4 2020 Results - Earnings Call Transcript
11:08pm, Thursday, 25'th Mar 2021
OpGen's (OPGN) CEO Oliver Schacht on Q4 2020 Results - Earnings Call Transcript
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates
06:11pm, Thursday, 25'th Mar 2021
OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -6.90% and 4.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OpGen's Earnings Outlook
10:04am, Wednesday, 24'th Mar 2021
OpGen (NASDAQ:OPGN) unveils its next round of earnings this Thursday, March 25. Get prepared with Benzinga's ultimate preview for OpGen's Q4 earnings.
OpGen, Inc. (OPGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:16pm, Thursday, 18'th Mar 2021
OpGen, Inc. (OPGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OPGN Stock Price Increases Over 40% Pre-Market: Why It Happened
04:58am, Tuesday, 09'th Mar 2021
The stock price of OpGen Inc (NASDAQ: OPGN) is trading at over 40% pre-market. This is why it happened.
Why Immunovant, Anchiano, OpGen Are Rallying Today
01:09pm, Monday, 08'th Mar 2021
Immunovant, Inc. (NASDAQ: IMVT), Anchiano Therapeutics Ltd. (NASDAQ: ANCN) and OpGen, Inc. (NASDAQ: OPGN) are among the biggest healthcare gainers on Monday.
OPGN Stock: 9 Things for OpGen Investors to Know as Shares Skyrocket
11:59am, Monday, 08'th Mar 2021
OpGen (OPGN) stock is flying high on Monday following results from a study published in a peer-reviewed publication concerning coronavirus. The post OPGN Stock: 9 Things for OpGen Investors to Know as
OPGN Stock Price Increases Over 10% Pre-Market: Why It Happened
08:30am, Monday, 08'th Mar 2021
The stock price of OpGen Inc (NASDAQ: OPGN) has increased by over 10% pre-market. This is why it happened.
Karolinska Institutet Study highlights Unyvero HPN demonstrating a higher diagnostic yield than bacterial culture, enabling rapid diagnosis of pathogens of concern in these patients
OPGN Stock Price Increases Over 12% Pre-Market: Why It Happened
08:42am, Monday, 01'st Mar 2021
The stock price of OpGen Inc (NASDAQ: OPGN) has increased by over 12% pre-market. This is why it happened.
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
07:30am, Monday, 01'st Mar 2021
GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help com
Study highlights best practice techniques for accurate antimicrobial resistance prediction from whole-genome sequencing data
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
07:30am, Wednesday, 13'th Jan 2021
GAITHERSBURG, Md., Jan. 13, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help comb
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
07:30am, Tuesday, 05'th Jan 2021
GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
07:30am, Wednesday, 09'th Dec 2020
Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of its growth
